Health catalyst, inc. HCAT.US AI Analysis
BetaUS StockHealthcare
(No presentation for HCAT)
HCAT Value Score
3
24
15
Average Growth
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
HCAT Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of HCAT from 2019-07-25 till Now
- -63.94%
- Cumulative Return
- -15.83%
- Annual Return
- 37.44%
- Volatility
- -0.42
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from July, 2019 to July, 2025. (Total Trades: 1)
| HCAT | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 48% | 58% |
| Avg Return | -64% | 46.7% | 61.1% |
| Avg Profit | - | 141.7% | 128% |
| Avg Loss | -64% | -40.2% | -32.2% |
| Avg Risk-Reward Ratio | - | 352.4% | 398.1% |